Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome

Código QR

Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome

Yun-Chun Zhao,1 Li Zhang,2 Shi-Sen Feng,3 Lu Hong,3 Hai-Li Zheng,3 Li-Li Chen,4 Xiao-Ling Zheng,1 Yi-Qing Ye,1 Meng-Dan Zhao,1 Wen-Xi Wang,3 Cai-Hong Zheng1 1Pharmacy Department, Women’s Hospital, 2Pharmacy Department, The Second Affiliated Hospital, School of Medicine, Zhejiang Universit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhao Y, Zhang L, Feng S, Hong L, Zheng H, Chen L, Zheng X, Ye Y, Zhao M, Wang W, Zheng C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	siRNA cationic cholesterol derivative Notch1 ovarian cancer cells Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/d111ead5713e44dcb9db23fe8276f80c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA
por: Zang X, et al.
Publicado: (2016)

Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells
por: Zhou Z, et al.
Publicado: (2017)

Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis
por: Diao L, et al.
Publicado: (2019)

D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming
por: Tan X, et al.
Publicado: (2019)

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi Y, et al.
Publicado: (2018)

Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Javad Khanali, et al.
Publicado: (2021)

Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes
por: Chen Z, et al.
Publicado: (2016)

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
por: Liu HM, et al.
Publicado: (2017)

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
por: Ngamcherdtrakul W, et al.
Publicado: (2018)

The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction
por: Cai W, et al.
Publicado: (2018)

VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
por: Chen J, et al.
Publicado: (2017)

Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy
por: Suñé-Pou M, et al.
Publicado: (2018)

Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes
por: Hemati M, et al.
Publicado: (2019)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia Y, et al.
Publicado: (2017)

Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy
por: Wang F, et al.
Publicado: (2018)

pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery
por: Shi M, et al.
Publicado: (2018)

Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system
por: Xiang B, et al.
Publicado: (2017)

Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells
por: Li Y, et al.
Publicado: (2016)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen M, et al.
Publicado: (2019)

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
por: Xia Y, et al.
Publicado: (2018)

Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation
por: Zhao MD, et al.
Publicado: (2016)

Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer
por: Zhang W, et al.
Publicado: (2019)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani G, et al.
Publicado: (2019)

GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers
por: Xu WW, et al.
Publicado: (2017)

Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy
por: Wang C, et al.
Publicado: (2020)

In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice
por: Shi Q, et al.
Publicado: (2018)

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng Y, et al.
Publicado: (2018)

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
por: Kubota K, et al.
Publicado: (2017)

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy
por: Yang Z, et al.
Publicado: (2018)

Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo
por: Sun Q, et al.
Publicado: (2018)

Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
por: Zhang J, et al.
Publicado: (2017)

Highly efficient siRNA transfection in macrophages using apoptotic body-mimic Ca-PS lipopolyplex
por: Lai Y, et al.
Publicado: (2018)

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
por: Kim JS, et al.
Publicado: (2018)

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat F, et al.
Publicado: (2018)

Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
por: Amir Nasrolahi Shirazi, et al.
Publicado: (2021)

Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes
por: Jin M, et al.
Publicado: (2018)

Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis
por: Sun P, et al.
Publicado: (2016)

Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
por: Zatsepin TS, et al.
Publicado: (2016)

Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different kinds of anticancer drugs
por: Li J, et al.
Publicado: (2016)

Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy
por: Si Chen, et al.
Publicado: (2021)